BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10489663)

  • 21. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease.
    Ito M; Kaise S; Suzuki S; Kazuta Y; Sato Y; Miyata M; Nishimaki T; Nakamura N; Kasukawa R
    Clin Rheumatol; 1999; 18(6):462-7. PubMed ID: 10638771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.
    Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T
    Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between the onset and outcome of interstitial pneumonia associated with polymyositis and dermatomyositis].
    Saku N; Ohno S; Sugiyama Y; Kitamura S
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):585-9. PubMed ID: 9805908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
    Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial Lung Disease in Polymyositis and Dermatomyositis.
    Long K; Danoff SK
    Clin Chest Med; 2019 Sep; 40(3):561-572. PubMed ID: 31376891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H; Enomoto N; Kono M; Fujisawa T; Inui N; Nakamura Y; Sumikawa H; Johkoh T; Nakashima R; Imura Y; Mimori T; Suda T
    PLoS One; 2015; 10(3):e0120313. PubMed ID: 25789468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
    Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
    Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive Association between
    Li L; Chen S; Wen X; Wang Q; Lv G; Li J; Yang F; Zhang F; Li Y
    Biomed Res Int; 2017; 2017():2905987. PubMed ID: 28470010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial lung disease in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
    Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
    Zhang L; Wu G; Gao D; Liu G; Pan L; Ni L; Li Z; Wang Q
    PLoS One; 2016; 11(5):e0155381. PubMed ID: 27171228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevation of cytokeratin 19 fragment in patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
    Fujita J; Dobashi N; Tokuda M; Bandoh S; Ohtsuki Y; Yamadori I; Yoshinouchi T; Ueda Y; Takahara J
    J Rheumatol; 1999 Nov; 26(11):2377-82. PubMed ID: 10555895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.
    Sun KY; Fan Y; Wang YX; Zhong YJ; Wang GF
    Semin Arthritis Rheum; 2021 Feb; 51(1):175-191. PubMed ID: 33383294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.
    Sugiyama Y; Yoshimi R; Tamura M; Takeno M; Kunishita Y; Kishimoto D; Yoshioka Y; Kobayashi K; Takase-Minegishi K; Watanabe T; Hamada N; Nagai H; Tsuchida N; Soejima Y; Nakano H; Kamiyama R; Uehara T; Kirino Y; Sekiguchi A; Ihata A; Ohno S; Nagaoka S; Nakajima H
    Arthritis Res Ther; 2018 Jan; 20(1):7. PubMed ID: 29325580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis.
    Kang EH; Lee EB; Shin KC; Im CH; Chung DH; Han SK; Song YW
    Rheumatology (Oxford); 2005 Oct; 44(10):1282-6. PubMed ID: 15972351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical impact of antineutrophil cytoplasmic antibody positivity on the occurrence of interstitial lung disease in patients with polymyositis/dermatomyositis.
    Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Ann Palliat Med; 2022 Oct; 11(10):3181-3192. PubMed ID: 36226644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
    Lung; 2009; 187(3):201-6. PubMed ID: 19387736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis.
    Shimizu T; Koga T; Furukawa K; Horai Y; Fujikawa K; Okada A; Okamoto M; Endo Y; Tsuji S; Takatani A; Umeda M; Fukui S; Sumiyoshi R; Kawashiri SY; Iwamoto N; Igawa T; Ichinose K; Tamai M; Sakamoto N; Nakamura H; Origuchi T; Mukae H; Kuwana M; Kawakami A
    J Intern Med; 2021 Feb; 289(2):206-220. PubMed ID: 32691471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis.
    Yamanaka Y; Baba T; Hagiwara E; Yanagawa N; Takemura T; Nagaoka S; Sakai F; Kuwano K; Ogura T
    Eur J Radiol; 2018 Oct; 107():26-32. PubMed ID: 30292269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
    Fathi M; Vikgren J; Boijsen M; Tylen U; Jorfeldt L; Tornling G; Lundberg IE
    Arthritis Rheum; 2008 May; 59(5):677-85. PubMed ID: 18438901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.